Looking for more information on the ongoing ADAPT Phase 3 clinical trial in MG? Click here.

Stock information

argenx shares were listed on the regulated market of Euronext Brussels on July 10, 2014 and of NASDAQ on May 17, 2017 under the symbol ARGX. argenx is a constituent of the Bel Small index. argenx has a total number of 32,292,368 outstanding shares.